A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Updates from The Motley Fool

Latest updates on Arena Pharmaceuticals from Fool.com.  The Fool has written over 400 articles on Arena Pharmaceuticals.
3 Dangerous Stocks

While investing in stocks is a great way to build wealth, there are some that should be avoided a...



Stock Performance

View Interactive ARNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arena Pharmaceuticals.
Current Price: $1.36
Prev Close: $1.30
Open: $1.32
Bid: $1.37
Ask: $1.41
Day's Range: $1.31 - $1.41
52wk Range: $1.20 - $2.16
Volume: 2,744,953
Avg Vol 3,024,788
Market Cap: $344M
P/E (ttm): -1.44
EPS (ttm): ($0.90)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arena Pharmaceuticals.
CAPS Rating 2 out of 5
 
760 Outperform
70 Underperform
CAPS All Stars
 
105 Outperform
14 Underperform

How do you think Arena Pharmaceuticals will perform against the market?



You pick for Arena Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jackie Lief, CEO

23% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arena Pharmaceuticals.

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers